Valuation : Yuhan Corporation

Market Cap 5,886B 4.39B 3.78B 3.56B 3.24B 6.07B 418B 6.09B 42.18B 16.3B 213B 16.49B 16.14B 675B P/E 2026 *
40.2x
P/E 2027 * 29.1x
Enterprise Value 5.81B 4.33M 3.73M 3.51M 3.2M 5.98M 412M 6.01M 41.61M 16.08M 210M 16.27M 15.92M 665M EV / Sales 2026 *
2.48x
EV / Sales 2027 * 2.24x
Free-Float
61.43%
Yield 2026 *
0.71%
Yield 2027 * 0.72%
1 day+1.14%
1 week-1.60%
Current month-4.42%
1 month-0.74%
3 months+4.30%
6 months-17.01%
Current year-28.83%
1 week 78,400
Extreme 78400
82,500
1 month 77,500
Extreme 77500
87,500
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 19/03/2021
Director of Finance/CFO 58 -
President 67 15/03/2024
Director TitleAgeSince
Chairman 74 19/03/2021
Director/Board Member 71 20/03/2015
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/06/25 Buy

Chairperson

200 0.0002%
25/06/25 Buy

Chief Executive Officer

720 0.0009%
24/06/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%-1.60%-33.28%+15.07% 4.45B
-1.29%-3.92%+74.19%+34.78% 364B
-0.72%-4.61%+21.09%-20.30% 67.05B
-0.27%-3.47%+41.04%+185.10% 12.19B
-0.81%-9.22%-12.91%-15.69% 7.58B
+0.72%-2.90%-23.40%+2.32% 4.9B
-1.63%-1.38%-35.25%-7.78% 2.96B
+0.56%-4.09%-8.74%+41.61% 2.45B
-1.31%-2.44%-25.62%-19.48% 1.96B
-0.82%-0.35%-25.00%-11.93% 1.7B
Average -0.43%-2.81%-2.79%+20.37% 46.92B
Weighted average by Cap. -1.07%-1.67%+60.39%+28.84%

Financials

2026 *2027 *
Net sales 2,340B 1.75B 1.5B 1.41B 1.29B 2.41B 166B 2.42B 16.77B 6.48B 84.66B 6.56B 6.41B 268B 2,556B 1.91B 1.64B 1.55B 1.41B 2.63B 181B 2.64B 18.31B 7.08B 92.45B 7.16B 7.01B 293B
Net income 154B 115M 98.71M 92.95M 84.69M 158M 10.92B 159M 1.1B 426M 5.56B 431M 421M 17.62B 206B 154M 132M 125M 113M 212M 14.62B 213M 1.48B 570M 7.45B 577M 565M 23.6B
Net Debt -80.13B -59.8M -51.45M -48.45M -44.15M -82.6M -5.69B -82.93M -574M -222M -2.9B -225M -220M -9.18B -162B -121M -104M -97.84M -89.15M -167M -11.49B -167M -1.16B -448M -5.85B -453M -444M -18.55B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
09/09/26 ₩80,000.00 +1.14% 141,783
08/09/26 ₩79,100.00 -1.98% 163,702
07/09/26 ₩80,700.00 -0.86% 178,343
04/09/26 ₩81,400.00 0.00% 108,985
03/09/26 ₩81,400.00 +0.12% 256,221
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
80,000.00KRW
Average target price
120,111.11KRW
Spread / Average Target
+50.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!